Trials / Sponsors / BioSight Ltd.
BioSight Ltd.
Industry · 4 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Phase I/II Dose Escalation and Expansion Study of BST-236 Plus Venetoclax in Patients With Unfit Newly Diagn AML, Adult | Phase 1 / Phase 2 | 2022-08-17 |
| Unknown | Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS AML, Adult, MDS, Relapse/Recurrence | Phase 2 | 2021-11-14 |
| Completed | Efficacy and Safety of BST-236 in Newly Diagnosed Acute Myeloid Leukemia Patients, Unfit for Standard Inductio Acute Myeloid Leukemia | Phase 2 | 2018-08-14 |
| Completed | Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukem Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1 / Phase 2 | 2015-09-01 |